← Back to Clinical Trials
Recruiting NCT07443579

NCT07443579 Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance Mammography

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07443579
Status Recruiting
Phase
Sponsor Royal College of Surgeons, Ireland
Condition Breast Cancer
Study Type INTERVENTIONAL
Enrollment 400 participants
Start Date 2026-02-24
Primary Completion 2028-12-31

Trial Parameters

Condition Breast Cancer
Sponsor Royal College of Surgeons, Ireland
Study Type INTERVENTIONAL
Phase N/A
Enrollment 400
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2026-02-24
Completion 2028-12-31
Interventions
Mammography View Sequencing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This prospective, single-centre, parallel-group randomised controlled trial evaluates the optimal sequencing of mammography views in women with a history of breast cancer undergoing surveillance mammography. Women treated with breast-conserving surgery within the previous five years will be randomised 1:1:1:1 to one of four mammography view sequencing groups. The primary objective is to compare patient-reported pain and satisfaction across sequencing groups. Secondary objectives include comparison of image quality (PGMI scoring), compression force, and breast thickness. A total of 400 participants will be enrolled at Beaumont Hospital Breast Care Centre over 2.5 years.

Eligibility Criteria

Inclusion Criteria: Female patients aged 18 years or older History of breast cancer treated with breast-conserving surgery (wide local excision) Undergoing first annual surveillance mammogram following completion of surgery and radiotherapy Within five years of breast cancer treatment May have history of whole-breast or partial-breast radiotherapy May have history of axillary surgery Able and willing to provide informed consent Exclusion Criteria: Male patients Patients younger than 18 years History of mastectomy History of bilateral wide local excision Lack of capacity to provide informed consent More than five years since completion of breast cancer treatment

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology